FDA Notifies Consumers Not to Use Bee Slim: AttorneyOne Monitors and Keeps Consumers Informed
San Diego, CA (PRWEB) November 27, 2014 -- AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Bee Slim.
The US FDA notified consumers on November 24, not to purchase or use Bee Slim due to undeclared drug ingredient. Bee Slim is promoted and sold for weight loss.
The reason for the public notification is that the product was found to contain Sibutramine. Sibutramine, removed from the market in 2010 for safety reasons, can significantly increase blood pressure and/or pulse rate and can pose a significant risk for patients with a history of arrhythmias, coronary artery disease, stroke, or congestive heart failure. Moreover, it can interact in life-threatening ways with other drugs that patients are taking.
Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning Bee Slim and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”
As the FDA notes “Do not purchase or use Bee Slim.” AttorneyOne.com has further information on Bee Slim at the website including the latest major drug, food, and medical products law news.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/09/prweb12356803.htm
Sean Burke, Attorney One, http://www.attorneyone.com/, +1 877-230-7343, [email protected]
Share this article